| Literature DB >> 33396614 |
Nídia Marques1, Manuela Bustorff1, Anabela Cordeiro Da Silva2,3, Ana Isabel Pinto2, Nuno Santarém2, Filipa Ferreira1, Ana Nunes1, Ana Cerqueira1, Ana Rocha1, Inês Ferreira1, Isabel Tavares1, Joana Santos1, Elsa Fonseca4, Conceição Moura4, André Cerejeira5, Júlia Vide5, Jorge Cancela6, Joana Sobrinho Simões7, Susana Sampaio1.
Abstract
Intracellular protozoan of the genus Leishmania, endemic in the Mediterranean basin, are the cause of cutaneous (CL), mucocutaneous (MCL), and visceral leishmaniasis (VL). A 75-year-old woman was admitted nine years after a second kidney transplant (KT), due to persistent pancytopenia and fever. She presented edema and erythema of the nose in the last two years and an exophytic nodular lesion located on the left arm, with areas of peripheral necrosis and central ulceration in the last 18 months. A bone marrow biopsy revealed features compatible with Leishmania amastigotes, and polymerase chain reaction test (PCR) for Leishmania infantum was positive. Moreover, biopsy and PCR for L. infantum of the cutaneous lesion on the patient's left arm and nose and PCR from peripheral blood were positive. Thus, a diagnosis of CL, MCL, and VL was made, and liposomal amphotericin B was initiated, but the patient had an unfavorable outcome and died. This is the first report of a KT recipient presenting with the entire spectrum of leishmaniasis. In Portugal, this infection is rare-so a high degree of clinical suspicion is required for its diagnosis, especially in endemic regions, as visceral leishmaniasis is a potentially life-threatening infection.Entities:
Keywords: immunosuppression; leishmaniasis; transplant
Year: 2020 PMID: 33396614 PMCID: PMC7824171 DOI: 10.3390/pathogens10010018
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817